A zebrafish model of combined saposin deficiency identifies acid sphingomyelinase as a potential therapeutic target
Tejia Zhang(University of Utah), Randall T. Peterson(University of Utah)
Cited by 13
Related Papers
In vivo drug discovery in the zebrafish
|Nature Reviews Drug Discovery|2005|1.4k
Progesterone receptor membrane component-1 regulates hepcidin biosynthesis
|Journal of Clinical Investigation|2015|111
Parallel Reaction Monitoring reveals structure-specific ceramide alterations in the zebrafish
|Scientific Reports|2019|17